Lisley Inata Mambelli - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Journal of Cancer|December 21, 2016

Advances and Challenges on Cancer Cells Reprogramming Using Induced Pluripotent Stem Cells TechnologiesDiana Aparecida Dias Câmara, Lisley Inata Mambelli, Allan Saj Porcacchia, et al.

Oncotarget|January 21, 2021

Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent in vivo and retards B16-F10 melanoma growth in a preclinical modelAdilson Kleber Ferreira, Brunella Cristofaro, Milene Cristina Menezes, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Journal of Cancer|December 21, 2016

Advances and Challenges on Cancer Cells Reprogramming Using Induced Pluripotent Stem Cells TechnologiesDiana Aparecida Dias Câmara, Lisley Inata Mambelli, Allan Saj Porcacchia, et al.

Oncotarget|January 21, 2021

Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent in vivo and retards B16-F10 melanoma growth in a preclinical modelAdilson Kleber Ferreira, Brunella Cristofaro, Milene Cristina Menezes, et al.

Pageof 1